(Q51760643)

11 April 2018

title

MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report. (English)

1 reference

11 April 2018

0 references

1 reference

extracellular vesicle

1 reference

8

1 reference

11 April 2018

Pellegrino Musto

17

1 reference

11 April 2018

Francesco La Rocca

Francesco La Rocca

2

0 references

Antonella Caivano

Antonella Caivano

1

0 references

Ilaria Laurenzana

Ilaria Laurenzana

6

0 references

Stefania Trino

Stefania Trino

9

0 references

Vittorio Simeon

Vittorio Simeon

3

0 references

author name string

Marco Girasole

4

1 reference

11 April 2018

Simone Dinarelli

5

1 reference

11 April 2018

Angelo De Stradis

7

1 reference

11 April 2018

Antonio Traficante

10

1 reference

11 April 2018

Giovanni D'Arena

11

1 reference

11 April 2018

Giovanna Mansueto

12

1 reference

11 April 2018

Oreste Villani

13

1 reference

11 April 2018

Giuseppe Pietrantuono

14

1 reference

11 April 2018

Luca Laurenti

15

1 reference

11 April 2018

Luigi Del Vecchio

16

1 reference

11 April 2018

publication date

19 October 2016

1 reference

11 April 2018

published in

Cellular Oncology

1 reference

11 April 2018

volume

40

1 reference

11 April 2018

issue

1

1 reference

11 April 2018

page(s)

97-103

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/s13402-016-0300-x

exact match

0 references

cites work

MicroRNA biogenesis pathways in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

MicroRNAs in cancer: biomarkers, functions and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Biological properties of extracellular vesicles and their physiological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Role of Extracellular Vesicles in Hematological Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Physiological roles of miR-155.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Regulation of the MIR155 host gene in physiological and pathological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Clinical significance of microRNAs in chronic and acute human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Structural, morphological and nanomechanical characterisation of intermediate states in the ageing of erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Clinical presentation and staging of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Prognostic factors and risk stratification in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

microRNA aberrations in Waldenström macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

International prognostic scoring system for Waldenstrom macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

'Acute myeloid leukemia: a comprehensive review and 2016 update'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Revised international prognostic scoring system for myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Myelodysplastic syndromes: Contemporary review and how we treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-016-0300-X

Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs

21 January 2018

1 reference

12 December 2020

MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation

1 reference

12 December 2020

miR-155 gene: a typical multifunctional microRNA.

1 reference

12 December 2020

Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application

1 reference

12 December 2020

Long non-coding RNAs in cancer: implications for personalized therapy

1 reference

12 December 2020

Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis

1 reference

12 December 2020

10.1007/S13402-016-0300-X

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

27761889

1 reference

11 April 2018